1. The role of REV-ERB in NASH
- Author
-
Griffett, Kristine, Hayes, Matthew E., Boeckman, Michael P., and Burris, Thomas P.
- Subjects
Pharmacology ,Non-alcoholic Fatty Liver Disease ,Nuclear Receptor Subfamily 1, Group D, Member 1 ,Animals ,Pharmacology (medical) ,Review Article ,Heme ,General Medicine ,Ligands ,Circadian Rhythm ,Transcription Factors - Abstract
REV-ERBs are atypical nuclear receptors as they function as ligand-regulated transcriptional repressors. The natural ligand for the REV-ERBs (REV-ERBα and REV-ERBβ) is heme, and heme-binding results in recruitment of transcriptional corepressor proteins such as N-CoR that mediates repression of REV-ERB target genes. These two receptors regulate a large range of physiological processes including several important in the pathophysiology of non-alcoholic steatohepatitis (NASH). These include carbohydrate and lipid metabolism as well as inflammatory pathways. A number of synthetic REV-ERB agonists have been developed as chemical tools and they show efficacy in animal models of NASH. Here, we will review the functions of REV-ERB with regard to their relevance to NASH as well as the potential to target REV-ERB for treatment of this disease.
- Published
- 2022
- Full Text
- View/download PDF